Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 902219 Boston, MA
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,822,641
+$465,070 QoQ
Shares Held
212,842
-11.9% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 207 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority Sole 0% Shared 70% None 30%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. AMLX ranks #15 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,379,025 $747,197,111
2 ZTS
Zoetis Inc.
 9,423,895 $677,201,094
3 TEVA
Teva Pharmaceutical Industries Ltd
 7,671,157 $259,898,795
4 ALKS
Alkermes plc.
 2,814,804 $147,495,727
5 LNTH
Lantheus Holdings, Inc.
 1,013,063 $112,389,207
6 ELAN
Elanco Animal Health Inc
 2,676,050 $65,857,589
7 HLN
Haleon plc
 3,273,583 $30,542,527
8 XERS
Xeris Biopharma Holdings, Inc.
 2,365,103 $18,731,613

All Filings in AMLX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,822,641 212,842
2026-03-31 $3,357,571 241,552
2025-12-31 $2,727,445 225,782
2025-09-30 $3,209,915 236,197
2025-06-30 $1,850,040 288,618
2025-03-31 $1,029,013 290,682
2024-12-31 $792,695 209,708
2024-03-31 $96,368 33,933
2023-12-31 $658,763 44,753
2023-06-30 $382,133 17,716
2023-03-31 $3,181,306 108,429
2022-12-31 $2,509,088 67,905